Researchers noted that despite the promising findings, more novel treatments are needed to overcome the disease’s resistance. Patients with penta-relapsed refractory multiple myeloma (RRMM) exhibited ...

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...

Researchers assessed overall survival outcomes in patients in France. Patients with multiple myeloma (MM) face a poor prognosis following relapse to multiple different lines of therapy (LOTs) and ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial) Eligible patients ...

The study focuses on patients unlikely to benefit from azacitidine/venetoclax or showing early resistance. ・SLS009 showed strong Phase 2 results in relapsed/refractory AML, surpassing 20% overall ...

Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 Teclistamab monotherapy delivered superior progression-free ...

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study Patients with RRMM who had received ≥ 2 prior lines of ...

Following a second injection at eight weeks, the patient maintained stable vision and remained dry at 12 weeks, allowing for ...

Chronic cough, defined as a cough lasting at least 8 weeks, affects approximately 5% of the European population, particularly older adults and individuals with a history of smoking. In some cases, ...